ABT Molecular Imaging
ABT's technology produces doses of molecular imaging drugs for positron emission tomography (PET scanning) at the point of use.
News
ABT Bags $6 Mil
ABT Molecular Imaging, a medical imaging company, has raised $6 million from River Cities Capital (which led the round), Mountain Group Capital, and Intersouth Partners. Rik Vandevenne of River Cities will join the company’s board.
